ENTITY

Stemline Therapeutics (STML US)

Health Care • United States

Stemline Therapeutics Inc. provides biopharmaceutical services. The Company offers research, discovery, and development of novel compounds that target cancer stem cells.

Refresh

Focused

No publications yet

There aren’t any syndicated reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00